VSee Health and Ava Robotics Partner to Develop Telepresence Solutions for the Hospital Inpatient Intensive Care Market
VSee Health (Nasdaq: VSEE) and Ava Robotics have partnered to develop telepresence solutions for the hospital inpatient intensive care market. The collaboration involves creating a VSee-powered Ava robot that enables providers to deliver personalized care remotely. This autonomous robot will operate in hospital ICUs, allowing skilled physicians to have a physical presence at the point of care, interact with patients, consult with onsite staff, and make real-time treatment decisions.
The initiative aims to expand telehealth accessibility beyond major metropolitan hospitals to regional and smaller ICUs. Dr. Imo Aisiku, co-CEO and Chairman of VSee Health, emphasized that this partnership will make world-class critical care available to every ICU in the country, potentially improving patient outcomes, reducing transfers, and lowering costs associated with critical care and stroke treatment.
VSee Health (Nasdaq: VSEE) e Ava Robotics hanno stretto una partnership per sviluppare soluzioni di telepresenza per il mercato delle terapie intensive ospedaliere. La collaborazione prevede la creazione di un robot Ava alimentato da VSee, che consente ai fornitori di offrire assistenza personalizzata da remoto. Questo robot autonomo opererà nelle terapie intensive degli ospedali, permettendo ai medici esperti di avere una presenza fisica nel punto di cura, interagire con i pazienti, consultarsi con il personale in loco e prendere decisioni di trattamento in tempo reale.
L'iniziativa mira a espandere l'accessibilità alla telemedicina oltre gli ospedali metropolitani principali alle terapie intensive regionali e più piccole. Il Dr. Imo Aisiku, co-CEO e Presidente di VSee Health, ha sottolineato che questa partnership renderà disponibili assistenza critica di classe mondiale in ogni terapia intensiva del paese, potenzialmente migliorando i risultati per i pazienti, riducendo i trasferimenti e abbattendo i costi associati all'assistenza critica e al trattamento degli ictus.
VSee Health (Nasdaq: VSEE) y Ava Robotics se han asociado para desarrollar soluciones de telepresencia para el mercado de cuidados intensivos hospitalarios. La colaboración implica la creación de un robot Ava impulsado por VSee que permite a los proveedores ofrecer atención personalizada de forma remota. Este robot autónomo operará en las unidades de cuidados intensivos (UCI) de los hospitales, permitiendo a médicos calificados tener presencia física en el punto de atención, interactuar con los pacientes, consultar con el personal en el lugar y tomar decisiones de tratamiento en tiempo real.
La iniciativa tiene como objetivo ampliar la accesibilidad a la telemedicina más allá de los grandes hospitales metropolitanos hacia UCI regionales y más pequeñas. El Dr. Imo Aisiku, co-CEO y Presidente de VSee Health, enfatizó que esta asociación hará que la atención crítica de clase mundial esté disponible en cada UCI del país, lo que potencialmente mejorará los resultados de los pacientes, reducirá las transferencias y disminuirá los costos asociados con la atención crítica y el tratamiento de accidentes cerebrovasculares.
VSee Health (Nasdaq: VSEE)와 Ava Robotics가 병원 입원 중환자 시장을 위한 원격 진료 솔루션을 개발하기 위해 협력했습니다. 이번 협력은 VSee의 기술이 탑재된 Ava 로봇을 만들어, 의료 제공자가 개인화된 치료를 원격으로 제공할 수 있도록 하는 것입니다. 이 자율 로봇은 병원 중환자실에서 활동하게 되며, 숙련된 의사들이 치료 지점에 물리적으로 존재하면서 환자와 상호작용하고, 현장의 직원들과 상담하며, 실시간으로 치료 결정을 내릴 수 있게 합니다.
이번 이니셔티브는 주요 대도시 병원을 넘어 지역 및 소규모 중환자실까지 원격 의료 접근성을 확대하는 것을 목표로 하고 있습니다. VSee Health의 공동 CEO이자 회장인 Dr. Imo Aisiku는 이 협력이 전국 모든 중환자실에서 세계 수준의 중환자 치료를 가능하게 할 것이라고 강조하며, 이는 환자의 결과를 개선하고 전환을 줄이며, 중환자 및 뇌졸중 치료와 관련된 비용을 낮출 수 있다고 언급했습니다.
VSee Health (Nasdaq: VSEE) et Ava Robotics se sont associés pour développer des solutions de téléprésence pour le marché des soins intensifs hospitaliers. Cette collaboration vise à créer un robot Ava alimenté par VSee, permettant aux prestataires de soins de dispenser des soins personnalisés à distance. Ce robot autonome opérera dans les unités de soins intensifs (USI) des hôpitaux, permettant à des médecins qualifiés d'avoir une présence physique au point de soins, d'interagir avec les patients, de consulter le personnel sur place et de prendre des décisions de traitement en temps réel.
Cette initiative vise à élargir l'accessibilité à la télémédecine au-delà des grands hôpitaux métropolitains aux USI régionales et plus petites. Dr. Imo Aisiku, co-CEO et président de VSee Health, a souligné que ce partenariat rendra disponible des soins intensifs de classe mondiale dans chaque USI du pays, ce qui pourrait améliorer les résultats pour les patients, réduire les transferts et diminuer les coûts associés aux soins intensifs et au traitement des AVC.
VSee Health (Nasdaq: VSEE) und Ava Robotics haben sich zusammengeschlossen, um Telepräsenzlösungen für den Markt der stationären Intensivpflege im Krankenhaus zu entwickeln. Die Zusammenarbeit umfasst die Schaffung eines von VSee betriebenen Ava-Roboters, der es Anbietern ermöglicht,personalisierten Pflege aus der Ferne zu leisten. Dieser autonome Roboter wird in den Intensivstationen von Krankenhäusern eingesetzt, sodass qualifizierte Ärzte eine physische Präsenz am Behandlungsort haben, mit Patienten interagieren, sich mit dem vor Ort befindlichen Personal beraten und Entscheidungen zur Behandlung in Echtzeit treffen können.
Die Initiative zielt darauf ab, den Zugang zur Telemedizin über große städtische Krankenhäuser hinaus auf regionale und kleinere Intensivstationen zu erweitern. Dr. Imo Aisiku, Co-CEO und Vorsitzender von VSee Health, betonte, dass diese Partnerschaft eine weltklasse Intensivpflege in jeder Intensivstation im Land verfügbar machen wird, was potenziell die Behandlungsergebnisse der Patienten verbessert, Überweisungen reduziert und die Kosten für die Intensivpflege und die Behandlung von Schlaganfällen senkt.
- Partnership with Ava Robotics to develop advanced telepresence solutions for ICUs
- Potential to expand telehealth services to regional hospitals and smaller ICUs
- Possibility of reducing patient transfers and associated costs in critical care
- First commercial product launched in June, with potential to improve tele-stroke operations
- None.
The partnership between VSee Health and Ava Robotics marks a significant advancement in telehealth technology, particularly for intensive care units (ICUs). This collaboration aims to develop a VSee-powered Ava robot that could revolutionize remote patient care in critical settings.
The key innovation here is the autonomous nature of the Ava Robot in ICU environments. This autonomy allows for a more seamless integration of remote expertise into the immediate patient care setting. The potential benefits are substantial:
- Improved access to specialized care in regional and smaller hospitals
- Real-time consultation and decision-making capabilities for remote physicians
- Potential reduction in patient transfers and associated costs
- Enhanced stroke care through improved tele-stroke operations
However, it's important to consider the challenges this technology might face:
- Ensuring reliable connectivity in hospital environments
- Training staff to effectively interact with and utilize the robotic system
- Addressing potential concerns about patient privacy and data security
- Navigating regulatory hurdles for autonomous medical devices
While the concept is promising, the success of this initiative will largely depend on its practical implementation and acceptance by healthcare providers and patients. The
The VSee Health and Ava Robotics partnership presents an intriguing value proposition for the healthcare industry, particularly in addressing the challenges faced by smaller and regional hospitals in providing specialized intensive care.
From an economic perspective, this technology could potentially:
- Reduce the need for costly patient transfers to larger, specialized facilities
- Optimize the utilization of scarce specialist resources across multiple locations
- Improve patient outcomes, potentially leading to shorter ICU stays and reduced healthcare costs
However, several economic considerations need to be addressed:
- The initial
investment cost for hospitals to adopt this technology - Potential changes in reimbursement models to account for robotic-assisted telehealth services
- The impact on staffing models and the potential for job displacement or role changes for on-site healthcare workers
It's worth noting that while the technology promises to make "the best critical care in the world available to every ICU in the country," the actual implementation and economic viability may vary significantly across different healthcare settings. The success of this initiative could potentially reshape the landscape of critical care delivery, but its widespread adoption will likely depend on demonstrable improvements in patient outcomes and cost-effectiveness.
Investors should closely monitor early adoption rates, patient outcome data and any changes in healthcare policies or reimbursement models that could affect the market potential for this technology.
The Ava Robot will be autonomous in the hospital intensive care unit (ICU), enabling skilled physicians to have a physical presence at the point of patient care, interact with patients, consult with onsite staff and make treatment decisions, all in real time. The Ava Robot, powered by VSee software, is intended to expand the reach of telehealth solutions beyond the largest hospitals in major metropolitan areas and make telehealth accessible to regional hospitals and smaller ICUs.
“Telehealth is among the most innovative advancement in medicine in the 21st century. Our goal under this new agreement with Ava Robotics is to make the best critical care in the world available to every ICU in the country,” said Imo Aisiku, M.D., co-CEO and Chairman of VSee Health. “We have the best-trained physicians in the world, and by integrating with Ava’s robotics we will be able to extend their reach and expertise to patients throughout
“Not only will patients receive the best expertise available and better care, regardless of location, but hospitals will be able to deliver a new, heightened level of care, reducing transfers and costs associated with critical care and stroke,” he added. “With the first commercial product launched in June, the Ava Robot is expected to be able to improve tele-stroke operations, and additional uses will be identified in the medical field as use of the Robot expands.”
About Ava Robotics
With deep technical heritage from iRobot, Ava Robotics is a robotics technology company that designs and builds intelligent robots for the workplace. Delivering on a vision of robots working with and for people, Ava's technology emphasizes user experience, safety and autonomous mobility to empower people, while advancing business operations and access. Learn more at www.avarobotics.com.
About VSee Health
VSee Health is a software-as-a-service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee Health’s system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days.
With a focus on patient disease state telemedicine and turnkey billing services, VSee Health has integrated an intensive care, critical care and neuro solution, powered by iDoc Telehealth Solutions, as its initial module for the VSee Health software platform. This technology encompasses a set of integrated telehealth technologies and a team of neurointensivists, neurologists, tele-radiologists that treat and coordinate care for acutely ill patients 24/7/365 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CS-ICU) and the intensive care unit (ICU) for stroke, brain trauma and a wide range of neurological conditions. For more information, please visit www.vseehealth.com.
Forward-Looking Statements
Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health’s ability to improve healthcare access and provider efficiencies, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the “Cautionary Note Regarding Forward-Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of VSee Health’s periodic and current filings with the SEC, which are also made available on VSee Health’s website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240801691285/en/
LHA Investor Relations
Tirth T. Patel
212-201-6614
tpatel@lhai.com
Source: VSee Health, Inc.
FAQ
What is the partnership between VSee Health and Ava Robotics for?
How will the Ava Robot function in hospital ICUs?
What are the potential benefits of the VSee-Ava Robotics partnership for VSEE stock?
When was the first commercial product from the VSee-Ava Robotics partnership launched?
